Absence of nucleophosmin leukaemic mutants in B and T cells from AML with NPM1 mutations: implications for the cell of origin of NPMc+ AML
MP Martelli, N Manes, V Pettirossi, A Liso, R Pacini… - Leukemia, 2008 - nature.com
Leukemia, 2008•nature.com
2 Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired
mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;
365: 1054–1061. 3 Gattenlohner S, Peter C, Bonengel M, Einsele H, Bargou R, Muller-
Hermelink HK et al. Detecting the JAK2 V617F mutation in fresh and'historic'blood and bone
marrow. Leukemia 2007; 21: 1559–1662. 4 Tefferi A, Strand JJ, Lasho TL, Knudson RA,
Finke CM, Gangat N et al. Bone marrow JAK2V617F allele burden and clinical correlates in …
mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005;
365: 1054–1061. 3 Gattenlohner S, Peter C, Bonengel M, Einsele H, Bargou R, Muller-
Hermelink HK et al. Detecting the JAK2 V617F mutation in fresh and'historic'blood and bone
marrow. Leukemia 2007; 21: 1559–1662. 4 Tefferi A, Strand JJ, Lasho TL, Knudson RA,
Finke CM, Gangat N et al. Bone marrow JAK2V617F allele burden and clinical correlates in …
2 Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054–1061. 3 Gattenlohner S, Peter C, Bonengel M, Einsele H, Bargou R, Muller-Hermelink HK et al. Detecting the JAK2 V617F mutation in fresh and’historic’blood and bone marrow. Leukemia 2007; 21: 1559–1662.
4 Tefferi A, Strand JJ, Lasho TL, Knudson RA, Finke CM, Gangat N et al. Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera. Leukemia 2007; published online 3 May. 5 Vannucchi AM, Antonioli E, Guglielmelli P, Rambaldi A, Barosi G, Marchioli R et al. Clinical profile of homozygous JAK2V617F mutation in patients with polycythemia vera or essential thrombocythemia. Blood 2007; Published online 22 March. 6 Tefferi A, Lasho TL, Schwager SM, Strand JS, Elliott M, Mesa R et al. The clinical phenotype of wild-type, heterozygous, and homozygous JAK2V617F in polycythemia vera. Cancer 2006; 106: 631–635.
nature.com
